Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Small Cell Lung Carcinoma × osimertinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Neoplasm Metastasis 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non-Small Cell Lung Cancer With EGFR Mutation 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 Mesothelioma 1 Lung Diseases 1 Inhibition, Psychological 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Etoposide 15 Carboplatin 14 pembrolizumab 13 Cisplatin 9 Topotecan 7 Nivolumab 7 Irinotecan 7 atezolizumab 6 Paclitaxel 5 PM 01183 5 Ipilimumab 5 Gemcitabine 5 olaparib 4 Temozolomide 4 Radiotherapy 4 surufatinib 3 durvalumab 3 carfilzomib 3 Docetaxel 3 Bevacizumab 3 veliparib 2 trilaciclib 2 sacituzumab govitecan 2 rovalpituzumab tesirine 2 obatoclax 2 navitoclax 2 lenvatinib 2 epacadostat 2 berzosertib 2 Vorinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡